NOVEL PIPERAZINYL-PYRAZINONE DERIVATIVES FOR THE TREATMENT OF 5-HT2A RECEPTOR-RELATED DISORDERS

Compounds of the general formula (I): (I)wherein m, n, R , R , R and R are as described in the specification. Further included are pharmaceutical compositions comprising the compounds, processes for their preparation, as well as the use of the compounds for the preparation of a medicament for the tr...

Full description

Saved in:
Bibliographic Details
Main Authors THOR, MARKUS, LUNDSTROEM, HELENA, NILSSON, BJOERN, CERNERUD, MAGNUS
Format Patent
LanguageEnglish
French
Published 29.01.2004
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Compounds of the general formula (I): (I)wherein m, n, R , R , R and R are as described in the specification. Further included are pharmaceutical compositions comprising the compounds, processes for their preparation, as well as the use of the compounds for the preparation of a medicament for the treatment of 5-HT2A receptor-related disorders or medical conditions. La présente invention concerne des composés de la formule générale (1) dans laquelle m, n, R , R , R et R sont tels que définis dans le descriptif. L'invention se rapporte également à des compositions pharmaceutiques comprenant lesdits composés, à des procédés de préparation de ces derniers, et à l'utilisation desdits composés dans la préparation d'un médicament destiné au traitement des troubles ou états médicaux liés au récepteur 5-HT2A.
Bibliography:Application Number: WO2003SE01102